Artiva grants CTO 40K RSUs, 120K options
Artiva Biotherapeutics granted its Chief Tech Operations Officer new stock options and restricted stock units, increasing his direct equity stake.
Rhea-AI Filing Summary
Artiva Biotherapeutics, Inc. (ARTV) reported that Chief Tech Operations Officer Christopher Horan received equity awards on September 9, 2026. He was granted 40,000 shares of Common Stock as a restricted stock unit award under the 2024 Equity Incentive Plan and options for 120,000 shares of Common Stock at an exercise price of $10.79 per share, expiring September 8, 2036. Following these awards, he directly holds 323,084 Common Shares and 120,000 stock options. The option award vests in equal monthly installments over four years, beginning September 8, 2026, and no Rule 10b5-1 trading plan is indicated.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 160,000 shares
Grant/Award
2 txns
Insider
Horan Christopher
Role
Chief Tech Operations Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) F2 | 120,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 40,000 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 120,000 contracts (Direct);
Common Stock — 323,084 shares (Direct)
Footnotes (2)
- F1. Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.
- F2. Beginning on September 8, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four-year period.
Key Figures
Restricted stock units granted: 40,000 shares
Stock options granted: 120,000 options
Option exercise price: $10.79 per share
+3 more
6 metrics
Restricted stock units granted
40,000 shares
Common Stock RSU award granted September 9, 2026 under the 2024 Equity Incentive Plan
Stock options granted
120,000 options
Employee Stock Option grant on September 9, 2026
Option exercise price
$10.79 per share
Exercise price for 120,000 Employee Stock Options expiring September 8, 2036
Option expiration date
September 8, 2036
Expiration of Employee Stock Options granted September 9, 2026
Common shares held after transaction
323,084 shares
Directly owned Common Stock after September 9, 2026 award
Option vesting schedule
1/48 per month over 4 years
Vesting begins September 8, 2026 for the 120,000-share option grant
Key Terms
restricted stock unit, Equity Incentive Plan, vesting, Rule 10b5-1
4 terms
restricted stock unit financial
"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Equity Incentive Plan financial
"award granted under the Issuer's 2024 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
vesting financial
"1/48th of the shares subject to the option shall vest in equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Rule 10b5-1 regulatory
"The filing’s Rule 10b5-1 checkbox is not checked for these awards"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did ARTV grant to Christopher Horan on September 9, 2026?
Christopher Horan received 40,000 shares of Common Stock as a restricted stock unit award and stock options for 120,000 shares of Common Stock at an exercise price of $10.79 per share, expiring on September 8, 2036.
What are the vesting terms of Christopher Horan’s new ARTV stock options?
Beginning on September 8, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over a four-year period, as disclosed in the footnote to the option grant.
Under which plan were Christopher Horan’s ARTV restricted stock units granted?
The 40,000-share restricted stock unit award was granted under Artiva Biotherapeutics’ 2024 Equity Incentive Plan, as stated in the footnote describing the transaction.
Were Christopher Horan’s ARTV transactions made under a Rule 10b5-1 plan?
No. The filing’s Rule 10b5-1 checkbox is not checked, so no Rule 10b5-1 trading plan is reported for the equity awards disclosed for Christopher Horan.
How many ARTV stock options does Christopher Horan hold after the grant?
Following the September 9, 2026 grant, Christopher Horan holds 120,000 stock options to acquire Artiva Biotherapeutics Common Stock, as shown by the total derivative securities reported after the transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
